Abstract
Myometrium myxoidosis is new terminology to describe a non-neo-plastic process of extracellular mucinous accumulation in the myometrium wall of the uterus. We report a rare association of myometrial myxoidosis with lupus erythematosus in a 35-year old woman with a history of leiomyoma. At presentation, this case was diagnosed as a pelvic abscess and treated with specific antibiotherapy, and then discharged after clinical improvement. One week later, after recurrence of the symptoms, the patient underwent hysterectomy with bilateral salpingo-oophorectomy and appendectomy with anterior abdominal soft tissue part resection. Pathological analysis revealed diffuse hypo-cellular myxoid areas intersecting the smooth muscle layer of the uterus and cervix in addition to a focal area in the interstitium of smooth muscles of the appendix and soft tissue of the anterior abdominal wall. This case emphasizes the importance of distinguishing between myxoid neoplastic and non-neoplastic lesions with myxoid changes.
SIMILAR CASES PUBLISHED:
To our knowledge, there are only two similar cases reported.
INTRODUCTION
Uterine mesenchymal tumors comprise a set of diagnostically-challenging neoplasms that predominantly involve the smooth muscles of the uterus and endometrial stroma.1 More specifically, myxoid lesions are uncommon and may be wrongfully-interpreted as myxoid leiomyomas.2 Myometrial myxoidosis is a pseudo-neoplastic myxoid reaction of the myometrium and is believed to cause myometrial thickening due to abnormal accumulation of myxoid substances.3 Differential diagnosis of such non-neoplastic lesions from other malignant uterine tumors seems plausible. In addition, its association with other systemic pathological conditions that may contribute to pathogenesis may be of considerable concern. In the present study, we report a rare association of myometrial myxoidosis with systemic lupus erythematosus (SLE) and review the relevant diagnostic features of this benign condition.
CASE
Presentation and history
A 35-year old patient presented to the emergency department with fever and abdominal pain evolving for about 3-4 weeks. The patient had a whitish vaginal discharge that started one month previously, followed by intermittent and dull abdominal pain and nausea without vomiting. A few days before presentation, she had severe suprapubic pain and fever with no dysuria, hematuria, bowel habits disorder or melena.
The patient had a history of SLE for the previous 4 years and had started prednisolone, methotrexate and hydroxychloroquine with a good therapeutic response. Surgically, she had a history of myomectomy, one year previously, for leiomyoma; the surgical report could not be reviewed because the intervention was done outside our hospital. The patient was never married and had no previous sexual activity before to exclude chronic inflammation secondary to sexually transmitted diseases, was nulliparous, having a regular menstrual cycle without menorrhagia, metrorrhagia or dysmenorrhea. There was no other medical history nor signs or symptoms of neurofibromatosis, scleroderma or other autoimmune disease.
Clinical examination and investigation
On examination, the patient was conscious and had a temperature of 38°C, a pulse of 95 beats/min, and 98/53 mm Hg blood pressure. On general examination, the skin was pale; no rash or pigmentation were noted. Abdominal examination revealed a soft lax abdomen, with a palpable suprapubic mass radiating to the right iliac fossa and this was associated with moderate tenderness over the area. The gynecological physical examination could not be done because the patient refused. Neurological clinical examination was normal. There was no evidence of palpable lymph nodes. The thyroid gland examination was normal. On radiological examination, a contrast enhanced CT-scan discovered two intra-abdominal collections; the first at the anterior extraperitoneal region measuring 6.6×4.1 cm and the second at the right iliac fossa measuring 3×3 cm. Other small subcutaneous collections were noted at the anterior midline abdomen. The uterus appeared bulky and hypodense; no well-defined lesion was identified. While both ovaries were unremarkable.
Management
The patient was admitted to the gynecology department for exploration of an abdominal collection. CT-guided drainage was performed at admission and a fluid culture showed positive non-typhoid Salmonella. Antibiotic therapy with ceftriaxone and metronidazole was started for the next ten days with rapid clinical improvement, including fever subsidence and a remarkable decrease in pain. The patient was discharged with metronidazole and cefuroxime for two weeks with a follow up appointment 2 weeks later. One week later, the patient presented again with fever and generalized abdominal pain. Surgery was indicated because of intractable chronic pelvic inflammatory disease and the patient underwent hysterectomy with bilateral salpingo-oophorectomy and appendectomy along with excision of a part of the anterior abdominal soft tissue. Intraoperative assessment showed firm adhesion between the bowel and posterior uterus wall with a myxomatous appearance of the uterus, along with a suspicious myxomatous anterior abdominal wall, which was also excised.
Macroscopy
All excised structures including the uterus, tubes and ovaries, as well as the appendix and a segment of anterior abdominal wall were macroscopically examined. The uterus showed a bulky enlargement measuring 13×10.5×7cm; and on section, the myometrial wall was diffusely thick (maximum thicknesses of 5cm), soft, tan and fleshy and dotted with small microcystic spaces filled with a clear fluid (Figure 1). Both ovaries and tubes were grossly unremarkable. The appendix measured 4.5×1.5 cm, the outer surface was congested and the mucosa was tan-pink. The segment of the anterior abdominal wall was soft and tan, measuring 5×3×2cm.
Figure 1. Gross image of the opened uterus, showing enlargement and thickened myometrium.

Microscopy
The entire section from the uterus showed hypocellular myxoid areas dissecting the smooth muscle bundles in a uterine section (Figure 2a). There was a multifocal mixture of chronic inflammatory cells and mucin-containing macrophages (muciphages) infiltrating the smooth muscle (Figure 2b). A chronic inflammation stigma was accentuated around the blood vessels [f] but no evidence of vasculitis was found (Figure 2c). The chronic inflammation and myxoid areas were also noted in focal areas of paratubal soft tissue of the fallopian tubes (Figure 2d), focal areas of muscle walls of the appendix (Figure 2e), cervix and soft tissue of the anterior abdominal wall (Figure 2f, 2g). The endometrium was weakly proliferative. The cervix mucosa, fallopian tubes and ovary were unremarkable. Alcian blue pH 2.5 and mucicarmine stains were diffusely positive in the inter-stitial myxoid of the myometrium (Figures 3a & 3b), whereas a Periodic acid–Schiff (without diastase) stain was negative (Figure 4). A gram-negative stain was negative. Immunohistochemistry showed that the myxoid hypocellular areas were positive for CD34 (Figure 5) and negative for S100, desmin, h-caldesmon smooth muscle action and anaplastic lymphoma kinase (ALK).
Figure 2. a) Uterus smooth muscle bundles interdissected by myxoid hypocellular areas; Hematolyn and eosin 4×. b) Mixture of chronic inflammation and mucinophages (arrow M) infiltrating the smooth muscle bundles; Hematolyn and eosin 10×; c) Lymphoid cells (arrows) aggregated around the blood vessels of uterus but no vasculitis; Hematolyn and eosin 4×; d) Paratubual soft tissue of fallopian tube showing myxoid areas (yellow arrow) and chronic inflammatory cells aggregates (black arrows); Hematolyn and eosin 4×; e) Appendix with focal myxoid areas (black arrows) in interstitium of between the smooth muscle bundles; Hematolyn and eosin 4×; f) Abdominal soft tissue shows chronic inflammation and mucinophages; Hematolyn and eosin 10×; g) High power mucinophages; Hematolyn and eosin 40×.

Figure 3. a) Alcin blue PH2.5, 4× and b) mucincarmin stain, are positive in uterus myxoid hypocellular areas, 10×.

Figure 4. Periodic acid–Schiff (PAS) is negative, 4×.

Figure 5. CD34 immunostain is positive in the myxoid hpocellular areas, 10×.

DISCUSSION
Myometrial myxoidosis is a newly recognized form of non-neoplastic myometrial change, which was first described by Veras et al in 2009.3 It is viewed as extracellular accumulations of mucin in the myometrial wall.3 We report a long-standing myxoid degeneration with chronic myometrial inflammation on a lupus background. Myxoid changes in the uterus have been described in several neoplastic conditions, such as myxoid leiomyoma, myxoid stromal sarcoma and myxoid leiomyosarcoma.4–6 Those lesions involving the myome-trial wall in the absence of neoplastic growth are rarely encountered, with a total of seven cases reported;2,3,7 of which two cases were associated with neurofibromatosis2,7 and two other patients experienced SLE.3 Our report adds another case of myometrial myxoidosis associated with SLE. Table 1 summarizes all cases of myometrial myxoidosis.
Table 1.
Reported cases of myometrial myxoidosis.
| Case; author | Clinical history | Morphology | Microscopic findings | Special stain | Immunohistochemistry |
|---|---|---|---|---|---|
| Veras et al3 (case 1) | A 34-year case of SLE with symptomatic leiomyoma | Weight=673g; 5cm myometrial thickness; not well-defined lesion | Myxoid appearance, hypocellular; no myxoid changes in cervix, tubes or ovary | MC: weakly positive; PAS (without diastase): negative; AB, pH 2.5: diffusely positive. Colloidal iron: diffusely positive | Not done |
| Veras et al3 (case 2) | A 52-year case of SLE with ascites | Weight: 674g; myometrial thickness not reported; 3 nodules in myometrial wall | Myxoid appearance; hypocellular in between the nonmyxoid leiomyoma; small lymphoid follicles noted; large arteries showing interstitial myxoid; cervix involved. | MC: weakly positive; PAS (without diastase): negative; PAS-AB, pH 2.5: diffusely positive for AB and negative for PAS; colloidal iron: diffusely positive; AB, pH 2.5: negative; AB, pH 1.0: weakly positive | Not done |
| McCluggage et al2 (case 1) | A 48-year case of type 1 NF; menorrhagia + history of oral progestogens and Mirena coil, and total hysterectomy + bilateral salpingo-oophorectomy | Weight: 77gr with leiomyoma nodule | Multiple foci of hypocellular myxoid material; deep cervical stroma involved; myxoid foci in both the inner and outer halves of the myometrium | Not performed | Positive for CD34 and CD10. Negative for SMA, desmin, h-caldesmon, ER, S100 and ALK1 |
| McCluggage et al2 (case 2) | 49-year-old; with subtotal hysterectomy and bilateral salpingooophorectomy | Weight: 250g; uterus totally necrotic and fibroid | Multiple foci of replacement of the myometrial smooth muscle outside the confines of the leiomyomas by hypocellular myxoid material; deep cervical stroma involved; myxoid foci in both the inner and outer halves of the myometrium | Not performed | Positive for CD34 and CD10. Negative for SMA, desmin, h-caldesmon, ER, S100 and ALK1 |
| McCluggage et al2 (case 3) | 46 years; subtotal hysterectomy +bilateral salpingooophorectomy for complex hyperplasia endometrium; + history of Mirena coil use | 500 g of uterus with leiomyoma | Nodule with single focus with myxoid focus; well circumscribed | Not performed | Positive for CD34 and CD10. Negative for SMA, desmin, h-caldesmon, ER, S100 and ALK1 |
| McCluggage et al2 (case 4) | 38-year-old woman; presumed uterine fibroids | 11 cm in maximum dimension; grossly myxoid myometrial | Smooth muscle extensively infiltrated by myxoid material | Not performed | Positive for CD34 and CD10. Negative for SMA, desmin, h-caldesmon, ER, S100 and ALK1 |
| Pugh et al7 | A 48-year case of type 1 NF asthma, hypertension, and postpartum pulmonary thromboembolism. Para 1, gravida 1 | The uterus and cervix: 85×50×35 mm. Weight is not available | Infiltration of the isthmus and deep cervical stroma by well-demarcated nodules of paucicellular, myxoid material. No necrosis, or vascular invasion. | Not performed | Positive for CD34 and CD10. Negative for SMA, desmin, h-caldesmon, ER, EMA |
| The present case | A 35-year-old patient; known case of SLE for 4 years; recurrent pelvic collection; underwent hysterectomy + bilateral salpingooophorectomy | Bulky enlarged uterus with thickened myometrium (5cm maximum thickness) | Diffuse hypocellular myxoid lesion dissecting the smooth muscle layer of uterus, cervix and pelvic organ | MC: diffusely positive AB, pH 2.5: positive; PAS and PAS-D: negative | Positive for CD34. Negative for CD10, SMA, desmin, h-caldesmon, ER, S100 and ALK1 |
ALK1: anaplastic lymphoma kinase; EMA: epithelial membrane antigen; ER: estrogen receptor; MC: mucicarmine; NF: neurofibromatosis; PAS: Periodic acid–Schiff; PAS-D: Periodic acid–Schiff–diastase; SMA: smooth muscle actin; SLE: systemic lupus erythematosus; AB:Alcian blue stain; MC: Mucicarmine stain.
SLE is an autoimmune disease characterized by vasculitis and chronic inflammation, which involves several organs including the skin, joints, kidneys, and gastrointestinal tract. The involvement of the gynecological system is rare; reported cases have presented with ovaritis, among other SLE manifestations.8 However, the case under study presented with pelvic collection and bacterial infection, which is an unusual presentation. The main histological finding was a striking myometrial mucinosis as confirmed by a special stain involving the outer two-thirds of the uterus, the cervix, the upper half of the vagina, and the paratubal area of the fallopian tube tissue, abdominal wall and focal areas of the mesoappendix. This is different from the previously reported myometrial myxoidosis in that it was limited to the uterus and cervix.3 We therefore suggest that the involvement of the uterus as well as the appendix and abdominal soft tissue may be a part of an unrecognized extension of SLE to the visceral organs.
The pathogenesis of myometrial mucinosis is uncertain. For our case, the association of lupus erythematosus raises the possibility of autoantibody- and cytokine-mediated stimulation of mucin production by myometrial fibroblast cells.9 Other possibilities include inhibition of hyaluronidase activities that lead to suppression of mucin degradation, resulting in excessive mucin accumulation.9 Interestingly, the interstitial myxoid lesions apparently mimic interstitial mucin deposition in patients with cutaneous lupus mucinosis.10
The abundance of myometrial and extrauterine myxoid involvement, including the peritoneum and appendix, highlights the importance of differentiation between myometrial myxoidosis and pseudomyxoma peritonei, which could be excluded due to the unre-markable epithelial surface lining of the appendix. Myometrial edema is another non-neoplastic condition that seems to be secondary to pregnancy11 and hence could be excluded. In this condition, the stroma shows separation of the myometrium but, unlike mucinosis, the alcian blue pH 2.5 special stain is negative.
Other differential diagnoses among neoplastic conditions include myxoid leiomyoma, inflammatory myofibroblast tumor (IMT) and myxoid changes in endometrial stromal sarcoma. Generally, these neoplasms usually form a mass, which was not the case in our patient. Myxoid leiomyoma is a non-infiltrative tumor composed of trapped islands of smooth muscle in myxoid tissue along with a background of large vessels. These findings were not detected in our case. IMT is a soft tissue tumor composed of myofibroblasts with a mixture of plasma cells, lymphocytes and eosinophils. They were composed of elongated myofibroblasts containing abundant eosinophilic cytoplasm and vesicular nuclei. Myxoid changes can be found in the stroma of spindled myofibroblasts and fibroblasts, which was not seen in our case. IMT is positive to vimentin, alpha smooth muscle actin, muscle specific actin and calponin, along with ALK expression in 40% of cases; all were negative in our case. Endometrial stromal sarcoma is formed of monotonous ovoid to a spindly cellular proliferation with minimal cytoplasm proliferating around small arterioles. This neoplasm is positively reactive to beta-catenin in 67%, ER, PR, and CD10, all of which were negative in our case.12 Immunologic IgG4-related disease is less likely in the differential diagnosis. It is composed of dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis and requires more than 40% of IgG4/IgG plasma cell ratio along with IgG4+ plasma cells more than 30 per high power field (HPF), which was not seen in our case. However, myxoid changes can occur in IgG4-related disease as a stromal reaction. However, the clinical, serological and radiological studies did not confirm a diagnosis of IgG4-related disease.
In conclusion, we report a very rare case of nonneoplastic myometrium myxoidosis associated with SLE, providing support to a hypothesized causal or pathogenic relationship between SLE and myxoid visceral changes. The crucial point, in this case, is for pathologists to be aware of the importance of the clinical history of the patient to correlate with histological changes and prevent over-interpretation of the findings as neoplastic lesions.
Funding Statement
None.
Conflict of interest The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Funding The author(s) received no financial support for the research, authorship and/or publication of this article.
REFERENCES
- 1.Sangle NA, Lele SM. Uterine mesenchymal tumors. Indian J Pathol Microbiol 2011;54:243-53. [DOI] [PubMed] [Google Scholar]
- 2.McCluggage WG, Young RH. Myxoid Change of the Myometrium and Cervical Stroma: Description of a Hitherto Unreported Non-neoplastic Phenomenon With Discussion of Myxoid Uterine Lesions. Int J Gynecol Pathol 2010;29:351-7. [DOI] [PubMed] [Google Scholar]
- 3.Veras E, Junkins-Hopkins JM, Marinis S, Vang R. Myometrial Myxoidosis: A Report of 2 Cases of a Distinctive Type of Secondary Myometrial Hypertrophy in Patients With Lupus Erythematosus. Int J Gynecol Pathol 2009;28:164-71. [DOI] [PubMed] [Google Scholar]
- 4.Kasashima S, Kobayashi M, Yamada M, Oda Y. Myxoid endometrial stromal sarcoma of the uterus. Pathol Int 2003;53:637-41. [DOI] [PubMed] [Google Scholar]
- 5.Mittal K, Popiolek D, Demopoulos R. Uterine myxoid leiomyosarcoma within a leiomyoma. Hum Pathol 2000;31:398-400. [DOI] [PubMed] [Google Scholar]
- 6.Cruz M, Murakami T, Tsuda K, Kurachi H, Enomoto T, Kim T, et al. Myxoid leiomyoma of the uterus: CT and MRI features. Abdom Imaging 2001;26:98-101. [DOI] [PubMed] [Google Scholar]
- 7.Pugh A, McCluggage WG, Hirschowitz L. Multifocal uterine myxoid change: a newly recognized association with neurofibromatosis type 1. Int J Gynecol Pathol 2012;31:580-3. [DOI] [PubMed] [Google Scholar]
- 8.Moncayo-Naveda H, Moncayo R, Benz R, WolfPro A, Lauritzen Ch. Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1989;160:1227-9. [DOI] [PubMed] [Google Scholar]
- 9.Terao H, Moroi Y, Urabe K, Koga T, Furue M. A Case of Nodular Cutaneous Lupus Mucinosis. J Dermatol 2003;30:341-3. [DOI] [PubMed] [Google Scholar]
- 10.Kanda N, Tsuchida T, Watanabe T, Tamaki K. Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis. J Cutan Pathol 1997;24:553-8. [DOI] [PubMed] [Google Scholar]
- 11.Phillips V. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol 2003;56:305-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 Cases. Mod Pathol 2001;14:465-71. [DOI] [PubMed] [Google Scholar]
